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Purpose: To realize cartilage regeneration which beneﬁts the
treatment of degenerative disorders such as osteoarthritis, fur-
ther understanding of mechanisms underlying chondrogenic dif-
ferentiation is essential. Aiming at elucidation of the molecular
network, this study initially sought to establish a monitoring sys-
tem that could detect chondrogenic differentiation in a precise,
noninvasive and real-time manner. Using the system, we per-
formed a screening for chondrogenic factors from our original
expression libraries, and succeeded in identiﬁcation of a key
molecule.
Methods: By comparison of the genomic sequences of intron 1
of type II collagen (COL2A1) gene among human, mouse and
rat, we identiﬁed a highly conserved region, and established
several lines of mouse chondrogenic ATDC5 cells stably trans-
fected with tandem copies of the region cloned upstream of
DsRed2 ﬂuorescence reporter gene. We then created retroviral
expression libraries from human tracheal cartilage and mouse
embryos, and applied the cell line to the expression cloning
for the screening of chondrogenic factors. Expression pattern
of the identiﬁed factor was evaluated by real-time RT-PCR, and
subcellular localization was detected by immunostaining with an
anti-myc-FITC antibody in HeLa cells overexpressing the myc-
tagged gene. For the functional analysis, ATDC5 cells and mouse
costal chondrocytes overexpressing the gene or the siRNA were
established through retroviral transfection, and COL2 mRNA level
and the promoter activity were determined by real-time RT-PCR
and luciferase-reporter assays, respectively. Phosphorylation of
signaling molecules was evaluated by Western blotting.
Results: We identiﬁed a 49 bp region including a SOX9 binding
enhancer in the COL2A1 promoter, and established a stable
clone called ATDC5-S2RD5 transfected with tandem copies of
the region that ﬂuoresced not only upon chondrogenic stimula-
tion by insulin, but also those by BMP-2, TGF-β, and SOX9/SOX6
co-transfection. This cell line was conﬁrmed to show increases
in endogenous COL2 expression and Alcian blue staining by
the stimulations above. The screening by expression cloning
from the retroviral expression libraries using the ATDC5-S2RD5
cell line identiﬁed several genes that caused ﬂuorescence by
chondrogenic stimulations. Among them, sorting nexin (SNX)
19, a member of the SNX family, intracellular transportation pro-
teins whose insufﬁciency is known to cause skeletal dysplasia
in human, exhibited strong ﬂuorescence. SNX19 was expressed
in cartilage, and the subcellular localization was limited in the
cytoplasm. Both mRNA level and promoter activity of COL2
were increased by the SNX19 overexpression, whereas they
were decreased by the knockdown through RNA interference in
the chondrogenic cells. Among signaling molecules ERK, p38
MAPK, JNK, Akt, IκB, Smads and GSK3β, the SNX19 over-
expression enhanced phosphorylation of p38. The p38 MAPK
pathway was conﬁrmed to be important for chondrogenic differ-
entiation, since ATDC5-S2RD5 cells showed strong ﬂuorescence
and an increase in Alcian blue staining by stable transfection with
constitutively active MKK6, an upstream kinase of p38.
Conclusions: We established a real-time ﬂuorescence cell line
ATDC5-S2RD5 for monitoring of chondrogenic differentiation.
Using this, we identiﬁed a novel chondrogenic factor SNX19
which was a cytoplasmic protein related to p38 MAPK signaling.
Further screening of molecules using this monitoring cell line
will elucidate the molecular network underlying chondrogenic
differentiation, leading to a new era of cartilage regeneration and
osteoarthritis treatment.
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A PROMINENT ROLE FOR WNT-1 INDUCED SECRETED
PROTEIN 1 AND UPREGULATION OF SEVERAL WNT
GENES IN EXPERIMENTAL AND HUMAN
OSTEOARTHRITIS
A.B. Blom1, S.M. Brockbank2, E.N. Blaney Davidson1, P.L. van
Lent1, P. Newham2, W.B. van den Berg1
1Radboud University Nijmegen Medical Center, Nijmegen, The
Netherlands; 2AstraZeneca, Respiratory and Inﬂammation
Research Area, Alderley Park, Macclesﬁeld, Cheshire, United
Kingdom
Purpose: In osteoarthritis (OA) it is proposed that developmental
processes important in embryonic development are reactivated in
cartilage. Several members of the wnt and frizzled (Fzd) families
are involved in embryonic development of cartilage and bone.
The aim of this study is to perform a longitudinal expression
analysis of wnt/Fzd- and related genes during development of
experimental models for OA and to validate the expression and
function of selected genes in OA disease models and through
histological analysis of human OA samples.
Methods: Experimental OA was induced by intra-articular in-
jection of collagenase into murine knee joints, which causes
local instability. Cartilage and synovial tissue were isolated from
injected and control knees at 7 days, 21 days and 42 days af-
ter induction. STR/ort mice were used as a second OA model.
Tissue of 4, 8 and 16 week old mice was isolated and com-
pared to expression in control (CBA) mice. mRNA was isolated
and analyzed by RT-PCR using Taqman Low Density Arrays, to
determine the expression level of 48 genes in 8 samples simul-
taneously. Expression of selected genes was tested on cartilage
from human OA patients and post mortem control patients using
Taqman RT-PCR and immunohistochemical staining of human
clinical samples. Functional relevance was tested by addition of
recombinant protein of the selected target(s) to chondrocytes
and macrophages, and by adenoviral overexpression in murine
knee joints.
Results: Several wnt-signaling genes were detected and/or reg-
ulated in the OA models, e.g. wnt16 and wnt2b that were strongly
upregulated (up to 100-fold). Wnt-1 induced secreted protein-1
(WISP-1) was strongly upregulated compared to control knee
joints. In the synovium, expression of WISP1 at day 7, 21 and
42 was increased 39-fold, 16-fold and 9-fold respectively. In the
cartilage, WISP1 expression was signiﬁcantly increased at day 7
and 21 (2.5-fold and 2.8-fold respectively). In a model for acute
arthritis, WISP1 was not regulated in cartilage, indicating speci-
ﬁcity for OA processes. In concordance with the experimental
OA, WISP1 expression in human OA knee joint cartilage was
signiﬁcantly upregulated (2.7 fold, p<0.03) compared to con-
trol cartilage. Small changes identiﬁed at the genomic level were
conﬁrmed using immunohistochemical staining, where strong up-
regulation of WISP1 in human cartilage was found, especially in
the mid zone and in chondrocyte clusters. Stimulation of murine
macrophages and chondrocytes using recombinant WISP1 pro-
tein resulted in high upregulation of MMP-3, -9 and -13 (respec-
tively 7-, 7- and 3-fold) in macrophages, which was independent
of IL-1. MMP-3 was also upregulated 14-fold in chondrocytes
by WISP1 stimulation. In a pilot study, overexpressing WISP1 in
naïve murine knee joints using an adenoviral vector resulted in a
signiﬁcant upregulation of the MMP and aggrecanase mediated
neoepitopes VDIPEN and NITEGE in the cartilage.
Conclusions: During experimental OA, Wnt-related processes
are regulated with upregulation of several wnts and enhanced
